Evaluation of the BD Max Cdiff assay for the detection of toxigenic Clostridium difficile in human stool specimens

Pathology

Volumn 47, Issue 2, 2015, Pages 165-168

  Putsathit, Papanin ^a   Morgan, Justin ^b   Bradford, Damien ^c   Engelhardt, Nelly ^a,d   Riley, Thomas V ^a,c  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b ROYAL PERTH HOSPITAL   (Australia)

^c PATHWEST LABORATORY MEDICINE   (Australia)

^d FREMANTLE HOSPITAL   (Australia)

Author keywords

BD Max Cdiff assay; C. Diff Chek 60; Clostridium difficile; Nucleic acid amplification test; Toxigenic culture

Indexed keywords

CHEMISTRY; CLOSTRIDIUM INFECTIONS; EVALUATION STUDY; FECES; HUMAN; ISOLATION AND PURIFICATION; MOLECULAR DIAGNOSIS; PEPTOCLOSTRIDIUM DIFFICILE; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; FECES; HUMANS; MOLECULAR DIAGNOSTIC TECHNIQUES; POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY;

EID: 84927626592     PISSN: 00313025     EISSN: 14653931     Source Type: Journal    
DOI: 10.1097/PAT.0000000000000214     Document Type: Article

References (25)

1. Jawa RS, Mercer DW. Clostridium difficile-associated infection: a disease of varying severity. Am J Surg 2012; 204: 836-42.
2. Bassetti M, Villa G, Pecori D., et al. Epidemiology, diagnosis and treatment of Clostridium difficile infection. Expert Rev Anti Infect Ther 2012; 10: 1405-23.
3. Alcala L, Sanchez-Cambronero L, Catalan M.P., et al. Comparison of three commercial methods for rapid detection of Clostridium difficile toxins A and B from fecal specimens. J Clin Microbiol 2008; 46: 3833-5.
4. US Food and Drug Administration. Nucleic acid based tests. 17 Jun 2014; cited Sep 2014. http://www.fda.gov/medicaldevices/productsandmedicalpro-cedures/invitrodiagnostics/ucm330711.htm
5. BD Diagnostics. BD GeneOhm Cdiff Assay. 17 Dec 2008; cited Sep 2014. http://www.accessdata.fda.gov/cdrh-docs/pdf8/K081920.pdf
6. Viala C, Le Monnier A, Maataoui N, et al. Comparison of commercial molecular assays for toxigenic Clostridium difficile detection in stools: BD GeneOhm Cdiff, XPert C. difficile and Illumigene C. difficile. J Microbiol Methods 2012; 90: 83-5.
7. Barbut F, Braun M, Burghoffer B., et al. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009; 47: 1276-7.
8. Stamper PD, Alcabasa R, Aird D., et al. Comparison of a commercial realtime assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J Clin Microbiol 2009; 47: 373-8.
9. Le Guern R, Herwegh S, Grandbastien B., et al. Evaluation of a new molecular test, the BD Max Cdiff, for detection of toxigenic Clostridium difficile in fecal samples. J Clin Microbiol 2012; 50: 3089-90.
10. Verhoeven PO, Carricajo A, Pillet S., et al. Evaluation of the new CE-IVD marked BD MAX Cdiff Assay for the detection of toxigenic Clostridium difficile harboring the tcdB gene from clinical stool samples. J Microbiol Methods 2013; 94: 58-60.
11. Leitner E, Einetter M, Grisold A.J., et al. Evaluation of the BD MAX Cdiff assay for the detection of the toxin B gene of Clostridium difficile out of faecal specimens. Diagn Microbiol Infect Dis 2013; 76: 390-1.
12. Dalpke AH, Hofko M, Zorn M., et al. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens. J Clin Microbiol 2013; 51: 1906-8.
13. Lyerly DM, Barroso LA, Wilkins TD. Identification of the latex test-reactive protein of Clostridium difficile as glutamate dehydrogenase. J Clin Microbiol 1991; 29: 2639-42.
14. Carson KC, Boseiwaqa LV, Thean S.K., et al. Isolation of Clostridium difficile from faecal specimens-a comparison of ChromID C. difficile agar and cycloserine-cefoxitin-fructose agar. J Med Microbiol 2013; 62: 1423-7.
15. Bowman RA, Riley TV. Laboratory diagnosis of Clostridium difficile-associated diarrhoea. Eur J Clin Microbiol Infect Dis 1988; 7: 476-84.
16. Kato N, Ou CY, Kato H, et al. Identification of toxigenic Clostridium difficile by the polymerase chain reaction. J Clin Microbiol 1991; 29: 33-7.
17. Kato H, Kato N, Watanabe K., et al. Identification of toxin A-negative, toxin B-positive Clostridium difficile by PCR. J Clin Microbiol 1998; 36: 2178-82.
18. Stubbs S, Rupnik M, Gibert M., et al. Production of actin-specific ADP-ribosyltransferase (binary toxin) by strains of Clostridium difficile. FEMS Microbiol Lett 2000; 186: 307-12.
19. Wilson KH. Efficiency of various bile salt preparations for stimulation of Clostridium difficile spore germination. J Clin Microbiol 1983; 18: 1017-9.
20. BD Diagnostics. BD MAX Cdiff Assay. 28 Mar 2013; cited Sep 2014. http://www.accessdata.fda.gov/cdrh-docs/pdf13/K130470.pdf.
21. Fenner L, Widmer AF, Goy G, et al. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J Clin Microbiol 2008; 46: 328-30.
22. Snell H, Ramos M, Longo S., et al. Performance of the TechLab C. DIFF CHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J Clin Microbiol 2004; 42: 4863-5.
23. Crobach MJ, Dekkers OM, Wilcox M.H., et al. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficile-infection (CDI). Clin Microbiol Infect 2009; 15: 1053-66.
24. Zheng L, Keller SF, Lyerly D.M., et al. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J Clin Microbiol 2004; 42: 3837-40.
25. Planche TD, Davies KA, Coen P.G., et al. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C. difficile infection. Lancet Infect Dis 2013; 13: 936-45.